- Home
- DYN vs CINT Comparison
DYN vs CINT Comparison
Compare DYN & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- CINT
- Stock Information
- Founded
- DYN 1984
- CINT 1995
- Country
- DYN United States
- CINT Brazil
- Employees
- DYN N/A
- CINT N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- CINT EDP Services
- Sector
- DYN Health Care
- CINT Technology
- Exchange
- DYN Nasdaq
- CINT Nasdaq
- Market Cap
- DYN 848.8M
- CINT 833.8M
- IPO Year
- DYN 2020
- CINT 2021
- Fundamental
- Price
- DYN $10.78
- CINT $5.15
- Analyst Decision
- DYN Strong Buy
- CINT Buy
- Analyst Count
- DYN 12
- CINT 6
- Target Price
- DYN $47.73
- CINT $7.72
- AVG Volume (30 Days)
- DYN 2.8M
- CINT 112.0K
- Earning Date
- DYN 05-05-2025
- CINT 05-21-2025
- Dividend Yield
- DYN N/A
- CINT N/A
- EPS Growth
- DYN N/A
- CINT 14.74
- EPS
- DYN N/A
- CINT 0.22
- Revenue
- DYN N/A
- CINT $438,961,000.00
- Revenue This Year
- DYN N/A
- CINT $537.19
- Revenue Next Year
- DYN N/A
- CINT $14.48
- P/E Ratio
- DYN N/A
- CINT $23.42
- Revenue Growth
- DYN N/A
- CINT N/A
- 52 Week Low
- DYN $6.36
- CINT $3.34
- 52 Week High
- DYN $47.45
- CINT $8.04
- Technical
- Relative Strength Index (RSI)
- DYN 57.30
- CINT 39.92
- Support Level
- DYN $7.38
- CINT $4.78
- Resistance Level
- DYN $8.01
- CINT $5.13
- Average True Range (ATR)
- DYN 0.91
- CINT 0.31
- MACD
- DYN 0.44
- CINT 0.04
- Stochastic Oscillator
- DYN 92.47
- CINT 53.28
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.